Tokyo Tape
Sign in
← Kubota Pharmaceutical Holdings

Quarterly report · Q3

4596.TEDINET S100PKP9
Period2022-01-01 → 2022-09-30
Filed2022-11-11
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 57
MetricValuePeriodScopeSource row
Revenue¥3m2022-01-01 → 2022-09-30Cons.Revenue IFRS (5-year summary)
Operating income−¥1.7bn2022-01-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income−¥481m2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Operating income−¥1.9bn2021-01-01 → 2021-09-30Cons.Operating profit loss IFRS
Operating income−¥573m2021-07-01 → 2021-09-30dCons.Operating profit loss IFRS
Profit before tax−¥1.7bn2022-01-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax−¥484m2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Profit before tax−¥2.6bn2021-01-01 → 2021-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax−¥1.9bn2021-01-01 → 2021-09-30Cons.Profit loss before tax IFRS
Profit before tax−¥580m2021-07-01 → 2021-09-30dCons.Profit loss before tax IFRS
Net income (owners)−¥1.7bn2022-01-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥484m2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥2.6bn2021-01-01 → 2021-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)−¥1.9bn2021-01-01 → 2021-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥580m2021-07-01 → 2021-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income−¥1.7bn2022-01-01 → 2022-09-30Cons.Profit loss IFRS
Net income−¥484m2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Net income−¥1.9bn2021-01-01 → 2021-09-30Cons.Profit loss IFRS
Net income−¥580m2021-07-01 → 2021-09-30dCons.Profit loss IFRS
Total assets¥4.7bnat 2022-09-30Cons.Assets IFRS
Total assets¥4.8bnat 2021-12-31Cons.Assets IFRS
Total assets¥5.4bnat 2021-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥623mat 2022-09-30Cons.Liabilities IFRS
Total liabilities¥680mat 2021-12-31Cons.Liabilities IFRS
Net assets / equity¥4.1bnat 2022-09-30Cons.Equity IFRS
Net assets / equity¥4.2bnat 2021-12-31Cons.Equity IFRS
Net assets / equity¥4.7bnat 2021-09-30Cons.Equity IFRS
Net assets / equity¥6.0bnat 2020-12-31dCons.Equity IFRS
Equity (owners)¥4.1bnat 2022-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥4.2bnat 2021-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥4.7bnat 2021-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥4.4bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥4.0bnat 2021-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥4.5bnat 2021-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥2.5bnat 2020-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow−¥1.7bn2022-01-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow−¥2.5bn2021-01-01 → 2021-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow−¥1.9bn2021-01-01 → 2021-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow¥566m2022-01-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow¥3.6bn2021-01-01 → 2021-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow¥3.5bn2021-01-01 → 2021-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥1.2bn2022-01-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥171m2021-01-01 → 2021-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥210m2021-01-01 → 2021-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-35.22022-01-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-9.452022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥-57.462021-01-01 → 2021-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥-42.52021-01-01 → 2021-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-12.662021-07-01 → 2021-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥-35.22022-01-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-9.452022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥-57.462021-01-01 → 2021-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥-42.52021-01-01 → 2021-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-12.662021-07-01 → 2021-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio86.8%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio85.9%at 2021-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio88.3%at 2021-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 434
ItemContextValueUnit
Liabilities IFRSPrior1YearInstant679643000JPY
Liabilities IFRSCurrentQuarterInstant622535000JPY
Share capital IFRSPrior1YearInstant1308902000JPY
Share capital IFRSCurrentQuarterInstant1916642000JPY
Capital surplus IFRSPrior1YearInstant26755419000JPY
Capital surplus IFRSCurrentQuarterInstant27370555000JPY
Retained earnings IFRSPrior1YearInstant-22164748000JPY
Retained earnings IFRSCurrentQuarterInstant-23845617000JPY
Other components of equity IFRSPrior1YearInstant-1746652000JPY
Other components of equity IFRSCurrentQuarterInstant-1358504000JPY
Equity attributable to owners of parent IFRSPrior1YearInstant4152921000JPY
Equity attributable to owners of parent IFRSCurrentQuarterInstant4083076000JPY
Equity IFRSPrior1YearInstant4152921000JPY
Equity IFRSCurrentQuarterInstant4083076000JPY
Liabilities and equity IFRSPrior1YearInstant4832564000JPY
Liabilities and equity IFRSCurrentQuarterInstant4705611000JPY
Operating revenue IFRSPrior1YTDDuration－JPY
Operating revenue IFRSCurrentYTDDuration2869000JPY
Cost of sales IFRSPrior1YTDDuration－JPY
Cost of sales IFRSCurrentYTDDuration2632000JPY
Research and development expenditure recognized as expense during period IFRSPrior1YTDDuration1500304000JPY
Research and development expenditure recognized as expense during period IFRSCurrentYTDDuration1305802000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration467916000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration421391000JPY
Total expenses IFRSPrior1YTDDuration1968220000JPY
Total expenses IFRSCurrentYTDDuration1729825000JPY
Other operating income IFRSPrior1YTDDuration59874000JPY
Other operating income IFRSCurrentYTDDuration73706000JPY
Operating profit loss IFRSPrior1YTDDuration-1908346000JPY
Operating profit loss IFRSCurrentYTDDuration-1653250000JPY
Finance income IFRSPrior1YTDDuration10086000JPY
Finance income IFRSCurrentYTDDuration10544000JPY
Finance costs IFRSPrior1YTDDuration14455000JPY
Finance costs IFRSCurrentYTDDuration9010000JPY
Other income IFRSPrior1YTDDuration-17857000JPY
Other income IFRSCurrentYTDDuration-29153000JPY
Other income and expenses net IFRSPrior1YTDDuration-22226000JPY
Other income and expenses net IFRSCurrentYTDDuration-27619000JPY
Profit loss before tax IFRSPrior1YTDDuration-1930572000JPY
Profit loss before tax IFRSCurrentYTDDuration-1680869000JPY
Profit loss IFRSPrior1YTDDuration-1930572000JPY
Profit loss IFRSCurrentYTDDuration-1680869000JPY
Profit loss attributable to owners of parent IFRSPrior1YTDDuration-1930572000JPY
Profit loss attributable to owners of parent IFRSCurrentYTDDuration-1680869000JPY
Basic earnings loss per share IFRSPrior1YTDDuration-42.50
Basic earnings loss per share IFRSCurrentYTDDuration-35.20
Diluted earnings loss per share IFRSPrior1YTDDuration-42.50
Diluted earnings loss per share IFRSCurrentYTDDuration-35.20
Profit loss IFRSPrior1YTDDuration-1930572000JPY
Profit loss IFRSCurrentYTDDuration-1680869000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2021-12-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-01-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-01-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2021-12-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass